Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Observational Safety Study During Administration of Topamac, as Monotherapy in Epileptic Patients With no Prior Treatment or Unsuccessfully Treated With Other Antiepileptic Drug

NCT00297323 is registered in ClinicalTrials.gov with Janssen Cilag Pharmaceutica S.A.C.I., Greece as lead sponsor.

NCT NCT00297323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Observational Safety Study During Administration of Topamac, as Monotherapy in Epileptic Patients With no Prior Treatment or Unsuccessfully Treated With Other Antiepileptic Drug
Lead sponsor
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
February 28, 2007
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

seizures, epileptic